BackX.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Goodwill

Latest goodwill for XTLB: $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00
100.00% YoYΔ $-3.19M vs prior year quarter

Peer trimmed avg / median

Loading

X.T.L. Biopharmaceuticals Goodwill History

Loading

X.T.L. Biopharmaceuticals vs. peers: Goodwill Comparison

Loading

X.T.L. Biopharmaceuticals Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

X.T.L. Biopharmaceuticals (XTLB) FAQ

X.T.L. Biopharmaceuticals (XTLB) currently reports a goodwill of $0 as of December 2025. That compares with $3.2M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore X.T.L. Biopharmaceuticals's goodwill history and peer comparisons.

X.T.L. Biopharmaceuticals's goodwill decreased from $3.2M to $0 — a 100.0% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

X.T.L. Biopharmaceuticals reported $0 in goodwill as of December 2025. That compares with $3.2M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for X.T.L. Biopharmaceuticals, and consider following XTLB for alerts when major investors trade the stock.

X.T.L. Biopharmaceuticals is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XTLB with unrelated industries.